Sunshine Biopharma Inc.

25/07/2011 | Press release | Archived content

SUNSHINE BIOPHARMA’S LEAD ANTI TUMOR COMPOUND, ADVA 27A, IS CLEARED VIA A CYTOCHROME P450 INDEPENDENT MECHANISM